Methotrexate-related lymphoproliferative disorder with extensive vascular involvement in a patient with rheumatoid arthritis

Journal of the American Academy of Dermatology

Volumn 61, Issue 1, 2009, Pages 126-129

  Shimura, Chieko ^a   Satoh, Takahiro ^a   Takayama, Kaoru ^a   Yokozeki, Hiroo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

EB virus; Hodgkin lymphoma; methotrexate; thrombophlebitis

Indexed keywords

CD20 ANTIGEN; CD30 ANTIGEN; CORTICOSTEROID; METHOTREXATE;

AGED; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN MANIFESTATION; SKIN ULCER; THROMBOPHLEBITIS;

AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; METHOTREXATE; SKIN DISEASES;

EID: 66949127955     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.10.051     Document Type: Article

References (27)

1. Asten P., Barrett J., and Symmons D. Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases. J Rheumatol 26 (1999) 1705-1714
2. Kamel O.W., van de Rijn M., Hanasono M.M., and Warnke R.A. Immunosuppression-associated lymphoproliferative disorders in rheumatic patients. Leuk Lymphoma 16 (1995) 363-368
3. Nalesnik M.A., Jaffe R., Starzl T.E., Demetris A.J., Porter K., Burnham J.A., et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133 (1988) 173-192
4. Loren A.W., Porter D.L., Stadtmauer E.A., and Tsai D.E. Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant 31 (2003) 145-155
5. Ikeda J., Morii E., Tomita Y., Xu J.X., Kimura H., Kohara M., et al. Methotrexate-associated lymphoproliferative disorder mimicking composite lymphoma. Int J Hematol 83 (2006) 363-365
6. Kim S.K., Kim I.S., and Jun J.B. Anaplastic large cell lymphoma in a patient with rheumatoid arthritis taking low dose methotrexate. Rheumatol Int 26 (2006) 775-776
7. Acero J., Navarro-Cuellar C., Menarguez J., Herencia H., and Navarro-Vila C. Naso-maxillary non-Hodgkin lymphoma associated with methotrexate treatment in a patient with rheumatoid arthritis. J Oral Maxillofac Surg 64 (2006) 708-711
8. Kamel O.W., van de Rijn M., Weiss L.M., Del Zoppo G.J., Hench P.K., Robbins B.A., et al. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328 (1993) 1317-1321
9. Tournadre A., D'Incan M., Dubost J.J., Franck F., Dechelotte P., Souteyrand P., et al. Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate. Mayo Clin Proc 76 (2001) 845-848
10. Kamel O.W., van de Rijn M., LeBrun D.P., Weiss L.M., Warnke R.A., and Dorfman R.F. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25 (1994) 638-643
11. Theate I., Michaux L., Dardenne S., Guiot Y., Briere J., Emile F.J., et al. Epstein-Barr virus-associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisolone. Eur J Haematol 69 (2002) 248-253
12. Paul C., Le Tourneau A., Cayuela J.M., Devidas A., Robert C., Molinie V., et al. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. Arch Dermatol 133 (1997) 867-871
13. Del Pozo J., Martinez W., Garcia-Silva J., Almagro M., Pena-Penabad C., and Fonseca E. Cutaneous ulceration as a sign of methotrexate toxicity. Eur J Dermatol 11 (2001) 450-452
14. Filosa G., Salaffi F., and Bugatti L. Accelerated nodulosis during methotrexate therapy for refractory rheumatoid arthritis: a case report. Adv Exp Med Biol 455 (1999) 521-524
15. Hoshida Y., Xu J.X., Fujita S., Nakamichi I., Ikeda J., Tomita Y., et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34 (2007) 322-331
16. Maruani A., Wierzbicka E., Machet M.C., Abdallah-Lotf M., de Muret A., and Machet L. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis. J Am Acad Dermatol 57 Suppl (2007) S69-S71
17. Salloum E., Cooper D.L., Howe G., Lacy J., Tallini G., Crouch J., et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14 (1996) 1943-1949
18. Feng W.H., Cohen J.I., Fischer S., Li L., Sneller M., Goldbach-Mansky R., et al. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 96 (2004) 1691-1702
19. Clarke L.E., Junkins-Hopkins J., Seykora J.T., Adler D.J., and Elenitsas R. Methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis presenting in the skin. J Am Acad Dermatol 56 (2007) 686-690
20. Verma S., Frambach G.E., Seilstad K.H., Nuovo G., Porcu P., and Magro C.M. Epstein-Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin. J Cutan Pathol 32 (2005) 474-483
21. Chai C., White W.L., Shea C.R., and Prieto V.G. Epstein Barr virus-associated lymphoproliferative disorders primarily involving the skin. J Cutan Pathol 26 (1999) 242-247
22. Takiwaki H., Adachi A., Kohno H., and Ogawa Y. Intravascular or intralymphatic histiocytosis associated with rheumatoid arthritis: a report of 4 cases. J Am Acad Dermatol 50 (2004) 585-590
23. Kimura H., Hoshino Y., Kanegane H., Tsuge I., Okamura T., Kawa K., et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 98 (2001) 280-286
24. Nakagawa A., Ito M., Iwaki T., Yatabe Y., Asai J., and Hayashi K. Chronic active Epstein-Barr virus infection with giant coronary aneurysms. Am J Clin Pathol 105 (1996) 733-736
25. Murakami K., Ohsawa M., Hu S.X., Kanno H., Aozasa K., and Nose M. Large-vessel arteritis associated with chronic active Epstein-Barr virus infection. Arthritis Rheum 41 (1998) 369-373
26. + NK/T-cell lymphoma are influenced by expression of cell adhesion molecules and cytotoxic granule and apoptosis-related proteins. Am J Clin Pathol 113 (2000) 201-211
27. Kanno H., Watabe D., Shimizu N., and Sawai T. Adhesion of Epstein-Barr virus-positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines. Clin Exp Immunol 151 (2008) 519-527